Scientific article
English

Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes

Published in

Journal of diabetes & metabolism, vol. 2, no. 4

Publication date

2011

Citation (ISO format)

FOUQUERAY, Pascale et al. Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes. In: Journal of diabetes & metabolism, 2011, vol. 2, n° 4. doi: 10.4172/2155-6156.1000126

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

2155-6156
1005views
1downloads

Technical informations

Creation

26/02/2015 15:59:00

First validation

26/02/2015 15:59:00

Update

14/03/2023 22:55:56

Status update

14/03/2023 22:55:56

Last indexation

30/10/2024 23:08:13
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated